文献速递临床试验与 GCP

EffEx-HN试验:头颈癌患者放疗期间综合监督运动项目对健康相关生活质量有效性与可行性随机对照试验的研究方案

EffEx-HN trial: study protocol for a randomized controlled trial on the EFFectiveness and feasibility of a comprehensive supervised EXercise program during radiotherapy in Head and Neck cancer patients on health-related quality of life.
PubMed 文献 · Trials · 2023-04-15

该随机对照试验将在鲁汶大学医院放疗科招募头颈癌患者,比较在常规支持治疗基础上加用12周综合监督运动项目(CSEP)与单纯常规支持治疗对健康相关生活质量的影响,主要终点为诊断后6个月的EORTC QLQ-C30评分;同时评估身体心理功能等次要结局及CSEP可行性。

要点

  • 头颈癌放化疗常导致身体和心理社会功能严重受损,患者治疗前体能已较差。
  • CSEP包括12周强化期(每周3次、每次1小时,6周后逐步减少监督)及后续居家维持期。
  • 主要终点为诊断后6个月EORTC QLQ-C30测量的健康相关生活质量。

核心结论

  • 研究旨在评估头颈癌治疗期间在常规支持治疗基础上加用CSEP对健康相关生活质量的有效性,并评估其可行性、障碍与促进因素。

研究设计与样本

  • 平行、开放标签随机对照试验,采用4例区组置换随机化,在鲁汶大学医院放疗科招募接受放疗的头颈癌患者。
  • 对照组接受当前标准支持治疗,干预组在相同常规支持治疗基础上加用CSEP。
  • 在参与者亚组中开展混合方法研究评估CSEP可行性。

主要发现

  • 原文为研究方案,尚未报告研究结果。

关键数值与推荐

  • CSEP强化期为12周,每周3次、每次1小时运动,6周后逐步减少监督。
  • 维持期自第13周起,患者居家运动并每月与物理治疗师进行远程咨询。
  • 结局在基线、6周、12周、6个月和诊断后12个月通过自报问卷和临床评估收集。
  • 主要终点为诊断后6个月EORTC QLQ-C30测量的健康相关生活质量。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With over 500,000 annually reported cases worldwide, head and neck cancer (HNC) is the seventh most common type of cancer worldwide. Treatment of HNC with chemoradiotherapy frequently results in serious impairments in physical and psychosocial functioning. Besides, HNC patients typically start their cancer treatment already with poor physical and psychosocial health. It has been shown that a sufficient level of physical activity (PA) before, during, and after cancer treatment is associated with fewer negative treatment-related side effects and a better quality of life (QOL). In order to prevent worsening of functioning and limit the physical impact of the HNC treatment, a comprehensive supervised exercise program (CSEP) may be beneficial during early cancer treatment. However, up to now, the feasibility and effectiveness of such a program are not yet investigated thoroughly in HNC. Therefore, the primary objective of this study is to examine the effectiveness of a CSEP during HNC treatment, in addition to usual supportive care, compared to usual supportive care alone, on health-related QOL up to 1 year post-diagnosis. Secondary objectives entail gathering information on (1) the effectiveness of a CSEP on secondary outcomes such as physical and mental function, activities of daily life, and participation in society and (2) the feasibility, possible barriers, and facilitators for participation in a CSEP during HNC treatment. METHODS: To investigate the effectiveness of the CSEP, a parallel, open-label randomized controlled trial will be performed. To study the feasibility of the CSEP, a mixed-method study will be performed in a subgroup of participants. HNC patients are eligible if they receive radiotherapy at the Radiation-Oncology department of the University Hospital of Leuven. A 4-size permuted block randomization will be used. The control group receives the current standard of supportive care. The intervention group receives a CSEP, additional to the same usual supportive care. The CSEP consists of a 12-week intensive phase with 3 exercise sessions of 1 h per week, where supervision is gradually reduced after 6 weeks. During the maintenance phase (from week 13), patients exercise at home with monthly tele-consultations with a physiotherapist. The CSEP contains supervised aerobic and resistance training. In both groups, outcomes of interest are evaluated through self-reported questionnaires and clinical assessments, at baseline, 6 weeks, 12 weeks, 6 months, and 12 months post-diagnosis. The primary endpoint is health-related QOL, measured with the EORTC QLQ-C30 at 6 months post-diagnosis. DISCUSSION: The study will be conducted in accordance with the Declaration of Helsinki. This protocol has been approved by the ethical committee of the University Hospitals Leuven (s65549). Recruitment started in January 2022. Results will be disseminated via peer-reviewed scientific journals and presentations at congresses. TRIAL REGISTRATION: Trial Registration: ClinicalTrials.gov Identifier: NCT05256238 Date of registration: February 25, 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Van Aperen K, De Groef A, Devoogdt N, et al. EffEx-HN trial: study protocol for a randomized controlled trial on the EFFectiveness and feasibility of a comprehensive supervised EXercise program during radiotherapy in Head and Neck cancer patients on health-related quality of life. Trials. 2023. PMID: 37061715. doi:10.1186/s13063-023-07170-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。